News

WASHINGTON, D.C.  – Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, sent a letter to Columbia University Acting President Claire Shipman questioning the university's compliance with federal anti-discrimination laws—particularly Title VI of the Civil Rights Act. The letter comes amid growing concerns that Columbia, which receives Medicare and Medicaid reimbursements and got  $690 million+ in National Institutes of Health (NIH) grants in FY2024 , has repeatedly failed to protect Jewish students, faculty, and patients from antisemitic harassment and discrimination, even though Columbia is required to do so as a recipient of federal funds and under the July 2025 agreement with the U.S. government. Some of the most glaring examples of deficiencies in Columbia’s attitude toward mitigating antisemitism that have raised concerns include: Withholding information  from a court-appointed federal Resolution Monitor; Deposition testimony  of the former Acting President (now the Chief Executive Officer (CEO) of Columbia Medical); A failing grade in a national December 2025  campus antisemitism report ; and A broader culture of antisemitism potentially exacerbated by New York City Mayor Zohran Mamdani’s  recent reversal   of the city’s adoption of the International Holocaust Remembrance Alliance (IHRA) definition of antisemitism. Chairman Guthrie issued the following statement in response to the Committee’s findings: “The Committee is troubled by recent reports and allegations raising questions about Columbia University’s willingness to uphold its commitments to protect Jewish students, faculty, and staff,”   said Chairman Guthrie.   “The fact that Columbia receives hundreds of millions of dollars from HHS and its subagencies, coupled with the serious concerns regarding its compliance with federal anti-discrimination laws, demonstrates that further oversight is needed. This Committee will continue to hold such institutions accountable that repeatedly foster environments of discrimination and harassment.” BACKGROUND: In May 2024, the House Committee on Energy and Commerce and the Committee on Education and the Workforce  opened investigations  into the extent to which HHS and NIH are ensuring that institutions receiving hundreds of millions of taxpayer dollars from HHS or NIH are complying with relevant federal civil rights laws and are providing safe environments for all, particularly those individuals of Jewish ancestry. In September 2024, the Committees  launched investigations  into incidents of antisemitism at three NIH-funded institutions, including Columbia University, as well as their medical schools and associated health care systems, and the Gladstone Institutes, an independent research institution. In October 2024, the Committees also  opened investigations  into the Advanced Research Projects Agency for Health (ARPA-H), an independent agency within NIH that has funded more than $595 million in biomedical and health research at institutions and organizations in 2024. The Committees’  investigation found  that HHS, NIH, and HHS OCR failed to act in the wake of emerging antisemitism across college campuses, medical schools, and medical systems. Prior HHS leadership refused to cooperate with congressional inquiries into their actions—or lack thereof—or require federal taxpayer-funded institutions to comply with civil rights laws and prevent antisemitism at their institutions. Today, the Committee is requesting that Columbia provide a comprehensive accounting of discrimination and harassment complaints, investigations, and outcomes since January 2023, including: Specific reporting of how many complaints involved antisemitism and how many were related or connected to individuals or institutions at Columbia that received NIH-funded grants; Details on the role and level of engagement in anti-discrimination compliance oversight of Dr. Katrina Armstrong, CEO of the Columbia University Irving Medical Center; and Information on how Columbia protects and supports victims of violations of federal anti-discrimination laws, including anonymous complainants, and whether tenure can be revoked for substantiated violations of federal anti-discrimination laws. CLICK HERE  to read the full letter.

WASHINGTON, D.C.  – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, Congressman John Joyce, M.D. (PA-13), Chairman of the Subcommittee on Oversight and Investigations, and Congressman Gary Palmer (AL-06), Chairman of the Subcommittee on Environment, sent a letter to Garney Companies, Inc., a contractor that was under consideration for an Emergency Master Service Agreement with DC Water to rehabilitate the Potomac Interceptor (PI) sewer line prior to its collapse on January 19, 2026.  “The collapsed portion of DC Water’s PI sewer line has resulted in what has been called ‘one of the largest sewage spills in U.S. history.’ The consequences of this spill continue to be evaluated, and the Committee remains concerned by the potential impacts to public health, safe drinking water, the environment, interstate commerce, and tourism,”  said Chairmen Guthrie, Joyce, and Palmer.  “The resilience of our wastewater infrastructure systems remains critical, and the Committee aims to understand what risks were determined prior to this incident and how future incidents may be prevented.”   Key excerpt from the letter:   “As part of its investigation, the Committee continues to obtain information from entities and individuals with knowledge that is relevant to this incident. According to the DC Water and Sewer Authority Board of Directors, Garney Companies, Inc (Garney) was under consideration for a potential Emergency Master Service Agreement for the PI rehabilitation, which was anticipated to begin on May 15, 2025. However, the contract was never finalized. The Committee is requesting information related to this contract and any additional information that your company may have related to the site of the PI wastewater collapse prior to the incident.   “It is the Committee’s understanding that the potential agreement between DC Water and   Garney would have covered a period of two years. The purpose of this contract was stated to   ‘[p]rovide program management, preconstruction and emergency construction services to   rehabilitate and provide redundancy for the Potomac Interceptor.’ Additionally, the project   scope included a number of repairs and upgrades to improve the reliability of this critical   Infrastructure.”   CLICK HERE   to read the full letter.  Background:   The Committee launched its investigation into the Potomac Interceptor collapse on February 20, 2026. Today’s letter to Garney represents the next step in uncovering what went wrong.   DC Water was considering an Emergency Master Service Agreement with Garney to “provide program management, preconstruction and emergency construction services to rehabilitate and provide redundancy” for the PI. That contract was anticipated to begin May 15, 2025, but the contract was never finalized.   The January 19, 2026, collapse of the PI sewer line has been called one of the largest sewage spills in U.S. history, with consequences for public health, safe drinking water, the environment, interstate commerce, and tourism still being evaluated.   The Committee is requesting all documents and communications related to Garney’s proposal, the unimplemented emergency contract, and information related to the collapse site prior to the incident—seeking to understand what risks were known beforehand and how future incidents can be prevented.  ###

WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, Congressman John Joyce, M.D. (PA-13), Chairman of the Energy and Commerce Subcommittee on Oversight and Investigations, and Congressman Morgan Griffith (VA-09), Chairman of the Energy and Commerce Subcommittee on Health, are continuing their ongoing investigation into waste, fraud, and abuse within Medicaid programs by sending letters to ten additional states to request information and documents on the actions each state is taking to strengthen Medicaid program integrity. These requests come amidst reports and law enforcement actions that have demonstrated high levels of Medicaid fraud across numerous states. For example, in Massachusetts, a woman pleaded guilty to fraudulently billing MassHealth for $500,000 in Personal Care Attendant, home health, and adult foster care services after enrolling disabled, elderly, and homeless people in services without their knowledge or consent and billing Medicaid as their caretaker despite not providing these services. In Colorado, two individuals were charged in separate cases for defrauding Health First Colorado’s non-emergency medical transportation (NEMT) program. The first defendant allegedly billed over $1 million in NEMT rides—$400,000 of which were billed for rides for herself and family members, and most of which were not associated with transportation to medical appointments. The second defendant billed Health First Colorado for $3.3 million in NEMT rides, including $283,000 for 64 rides for a single beneficiary, $165,000 of which occurred after the beneficiary had died. In Oregon, a woman was sentenced to federal prison for using stolen identities to submit fraudulent health care claims to Oregon’s Medicaid Program, totaling over $3 million and triggering $1.5 million in fraudulent Medicaid reimbursements. In New York, two individuals involved in a Brooklyn-based scheme involving adult day cares and home health  pleaded guilty   to $68 million in Medicaid fraud over a seven-year period. In addition, two men in Queens who owned adult daycare centers and a pharmacy  were recently charged  with $120 million in alleged Medicaid and Medicare fraud schemes. This included illegal kickbacks to Medicaid recipients to fill prescriptions at their pharmacies and enroll in their adult day care. It’s no secret that Medicaid fraud schemes have possibly cost the program billions of dollars annually across the country. These schemes contribute greatly to rising health care costs and strain our health care system, all at the expense of Medicaid beneficiaries and taxpayers. The Committee on Energy and Commerce is committed to rooting out waste, fraud, and abuse in our government health programs like Medicaid to ensure Americans who need them get the quality, affordable care they deserve. Chairmen Guthrie, Joyce, and Griffith issued the following statements regarding the ongoing investigation: “Fraud shouldn’t be a partisan issue. It's our most vulnerable Americans who are most at risk from fraudsters diverting precious resources intended for critical, needed care , ” said Chairman Guthrie. “ We owe it to our fellow Americans to preserve the Medicaid program for those that need it most, and states have an important role to play in ensuring that Medicaid programs operate with integrity. The Committee will continue to combat rampant waste, fraud, and abuse across the entire country.” "Medicaid was established to ensure the most vulnerable Americans are never left behind. That is why fraud and abuse within Medicaid will not be tolerated. Medicaid fraud robs both taxpayers and patients, and we will pursue it wherever it hides," said Rep. John Joyce, M.D. "Expanding this investigation is part of our responsibility in Congress to ensure that the government upholds the standards it was created to serve. Our Committee will work diligently to strengthen the integrity of the Medicaid system and to ensure that those who engage in fraudulent misuse or abuse are held fully accountable." “Americans support federal health care programs that serve American communities, not fraudsters! Led by the House Committee on Energy and Commerce, this latest series of letters is the next step in our investigations to protect our social safety net programs and secure them for the most vulnerable Americans,” said Rep. Griffith. “Republicans in Congress will continue to do the necessary legwork to investigate allegations of waste, fraud and abuse within our Medicaid system.” BACKGROUND: In January, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, Congressman John Joyce, M.D. (PA-13), Chairman of the Energy and Commerce Subcommittee on Oversight and Investigations, and Congressman Morgan Griffith (VA-09), Chairman of the Energy and Commerce Subcommittee on Health, wrote to Minnesota Governor Tim Walz and the Temporary Commissioner of Minnesota’s Department of Human Services, Shireen Gandhi, requesting communications, documents, and information to better understand the ongoing Medicaid fraud occurring in the state of Minnesota and actions the state is taking to strengthen program integrity. On February 3, the Subcommittee on Oversight and Investigations held a hearing titled Common Schemes, Real Harm: Examining Fraud in Medicare and Medicaid . During this hearing, expert witnesses testified on common examples of Medicaid fraud schemes and the potential scale of fraud in Medicaid programs nationwide. Now, as part of the Committee’s ongoing efforts to address Medicaid fraud, the Committee sent letters to CA , CO , MA , ME , NE , NY , OR , PA , VT , and WA . Each of these states displayed concerning cases of Medicaid fraud over the last several years. The purpose of this investigation is to assess the extent of fraud in state Medicaid programs and understand what states are doing to address the issue and protect the integrity of Medicaid for Americans. Read More About this Ongoing Investigation: CLICK HERE to read the New York Post's exclusive coverage of the letter.

WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, Congressman John Joyce, M.D. (PA-13), Chairman of the Energy and Commerce Subcommittee on Oversight and Investigations, and Congressman Morgan Griffith (VA-09), Chairman of the Energy and Commerce Subcommittee on Health, are requesting communications, documents, and information from Minnesota Governor Tim Walz and the Temporary Commissioner of Minnesota’s Department of Human Services, Shireen Gandhi, to better understand the ongoing Medicaid fraud occurring in the state of Minnesota and actions the state is taking to strengthen program integrity.

The unprecedented fraud scheme in Minnesota, which has potentially been ** ongoing ** since 2013, has revealed a swath of criminal schemes, including overbilling, false records, identity theft, and phantom claims in Medicaid social service and health programs for the elderly and disabled, people struggling with addiction, and homelessness. Chairmen Guthrie, Joyce, and Griffith issued the following statement regarding ** the letter’s ** content:

“The extensive fraud schemes being perpetrated in Minnesota have wreaked havoc on government-funded health programs. We have an obligation to ensure finite taxpayer dollars are being used responsibly, and that the most vulnerable Americans are not being exploited to the benefit of fraudsters and foreign actors,” said Chairmen Guthrie, Joyce, and Griffith. “As members of Congress and this Committee, our track record has made our continued commitment to ridding government programs of waste, fraud, mismanagement, and abuse clear. This letter is the next step in the Committee’s work to root out fraud and restore program integrity in our federal health programs nationwide.”

The Trump Administration has taken concrete steps to address the fraud being uncovered in Minnesota. Complementary to that work, Congress has a responsibility to oversee federal programs, like Medicaid, to ensure precious dollars and resources are being spent appropriately to deliver quality and necessary care.

BACKGROUND:

Glaring accounts of waste, fraud, and abuse in Minnesota’s Medicaid social service and health programs have resulted in billions of taxpayer dollars going straight to the pockets of fraudsters and foreign actors.

• Ongoing investigations indicate that fraudulent provider schemes are particularly prevalent in health and community-based service programs, including residential drug and alcohol treatment, home health, housing, and autism service programs.

Unfortunately, Minnesota’s Medicaid program lacks adequate oversight and fraud control measures, and state officials have neglected to swiftly identify and address vulnerabilities in programs.

• Fraud experts note that fraudsters often target states like Minnesota, which tend to have the “weakest ID checks, fastest payouts, and lowest audit risk,” when looking to establish fraud schemes.

In July 2025, the Working Families Tax Cuts legislation was signed into law by President Trump, including critical provisions to target waste, fraud, and abuse within the Medicaid program—several of which help prevent the fraud schemes that occurred in Minnesota from happening again.

In response to these fraudulent practices, CMS is auditing the Minnesota Medicaid program, freezing provider enrollment, and deferring payments for 14 high-risk programs, including adult companion, rehabilitative mental health services, individualized home supports, residential treatment services, among others—which, alone, cost taxpayers $3.75 billion annually.

CMS recently briefed the Committee on what is currently known about the Medicaid fraud in Minnesota and actions CMS has taken to date. This further underscored the need for the Committee’s oversight to ensure program integrity.

WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, Congressman John Joyce, M.D. (PA-13), Chairman of the Energy and Commerce Subcommittee on Oversight and Investigations, Congressman Morgan Griffith (VA-09), Chairman of the Energy and Commerce Subcommittee on Health, Congressman Jason Smith (MO-08), Chairman of the House Committee on Ways and Means, Congressman David Schweikert (AZ-01), Chairman of the Ways and Means Subcommittee on Oversight, and Congressman Vern Buchanan (FL-16), Chairman of the Ways and Means Subcommittee on Health, authored ** a letter ** to the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) requesting a meeting on the concerning evidence detailed in the letter that points to large-scale, ongoing Medicare fraud in Los Angeles County, along with what action is being taken to address the situation.

“The House Committee on Energy and Commerce has an extensive history of digging deeper into matters where program integrity has been compromised. This letter is crucial in our commitment to eliminating waste, fraud, and abuse in federal health care programs,” said Chairmen Guthrie, Joyce, and Griffith. “Republicans have spent much of this Congress furthering legislation to protect our most vulnerable Americans—especially seniors, but our work is not done. Continued oversight is crucial to uphold the integrity of programs that serve our most vulnerable populations. We applaud the ongoing work being conducted by HHS-OIG in cracking down on the fraud that has occurred, and we look forward to addressing the larger-scale scheme that is draining public resources from Americans who need these services the most.”

“Medicare home health and hospice fraud directly undermines the safety and reliability of care for America’s most vulnerable seniors. Auditors have reported an unprecedented jump in home health and hospice fraud in Los Angeles County, California – including one report showing 112 different hospices located at the same physical address. With $1.2 billion in improper payments in home health claims and the Inspector General reporting $198 million in suspected hospice fraud, Gavin Newsom’s California could just as well be another Minnesota,” said Chairman Smith. “The Ways and Means Committee will not hesitate to use our broad oversight authority to get to the bottom of this and protect taxpayers and vulnerable patients against these bad actors.”

BACKGROUND:

Evidence has strongly suggested large-scale Medicare fraud involving home health agencies (HHA) and hospice agencies in Los Angeles County, California, noting that such practices not only drain public resources but also compromise the quality of care provided to patients, especially those most vulnerable populations.

• The Centers for Medicare and Medicaid Services (CMS) found that the 2023 improper payment error rate for home health claims was 7.7 percent, or about $1.2 billion, in 2023.
• In terms of hospice care, HHS OIG reported suspected hospice fraud to be an estimated $198.1 million in fiscal year (FY) 2023.
• CMS has placed HHAs as an area of high risk for Medicare fraud.

Emerging concerns over Medicare fraud in the HHAs and hospice sector highlights heightened activity, specifically in Los Angeles County.

• From 2019 through June 2023, HHAs in the U.S. decreased from 8,838 to 8,280 (6 percent), while, at the same time, HHAs in Los Angeles County increased from 896 to 1,309 (46 percent).
• More than 1,400 new Los Angeles County HHAs enrolled in Medicare in the last five years, representing over 50 percent of all HHAs in the state of California and nearly 14 percent of all HHAs in the country.

Based on data from the March 2022 California State Auditor’s Report and from HHS on hospice ownership, Los Angeles County had more than 31 percent of the hospice agencies in the U.S. in 2022.

• There were approximately 58 million seniors in the U.S. in 2022, with Los Angeles County having approximately 1.49 million seniors (2.5 percent).
• The report highlighted indicators that included a “rapid, disproportionate growth in the number of hospice agencies” and “excessive geographic clustering of hospice agencies,” noting that 112 different licensed hospice agencies were located at the same physical address.
• State auditors in California estimated that hospice agencies in Los Angeles County likely overbilled Medicare by $105 million in 2019.

These accounts of widespread fraud occurring in Los Angeles County’s HHAs and hospice agencies have raised concerns about whether home health and hospice Accrediting Organizations (AO) are effectively examining such organizations at the time of their enrollment in Medicare.

• In November 2024, CMS issued a Quality, Safety, and Oversight memo to surveyors, reminding them to closely inspect hospices’ Medicare enrollment documents to understand changes in ownership and location, but neglecting to encourage AOs to pursue other commonsense antifraud measures.

In April 2025, HHS OIG announced that the Office of Audit Services would compile a report for FY 2026 to identify trends, patterns, and comparisons that could indicate potential vulnerabilities related to new Medicare hospice provider enrollments.

In May 2025, the Health Care Fraud Strike Force—a joint task force of federal, state, and local law enforcement agencies, including HHS OIG—** announced multiple arrests ** following a multi-year investigation into Armenian Organized Crime, which dismantled five hospices in the greater Los Angeles area.

On November 28, 2025, CMS ** announced ** the Calendar Year 2026 Home Health Prospective Payment System Final Rule, providing comments that suggest an interest in addressing the aforementioned accounts of fraud.

WASHINGTON, D.C. – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, Congressman John Joyce, M.D. (PA-13), Chairman of the Subcommittee on Oversight and Investigations, and Congressman Gary Palmer (AL-06), Chairman of the Subcommittee on Environment, sent a letter to Steven S. Cliff, Ph.D., Executive Officer of the California Air Resources Board (CARB), demanding answers and documents that the Committee previously requested from CARB on California’s refusal to follow the law and implement the Clean Air Act as written by Congress. The Committee also requested transcribed interviews of six individuals if CARB fails to provide the previously requested information by December 5, 2025.    “The Committee’s August 11, 2025, letter requested information and documents from the California Air Resources Board (CARB) about California’s enforcement of state vehicle emission standards that disregard recent Congressional actions to disapprove waivers of federal preemption under the Clean Air Act,” said Chairmen Guthrie, Joyce, and Palmer. “Unfortunately, CARB’s responses to date have been woefully inadequate and do not satisfy the Committee’s important oversight interests in this matter.” Key excerpt from the letter: “Clean Air Act section 209(a) preempts states from adopting or attempting to enforce any emissions control standard for new motor vehicles or engines, or any condition precedent to the initial retail sale, registration or inspection of such vehicle or engine. Under section 209(b), the U.S. Environmental Protection Agency (EPA) may waive federal preemption, allowing California to establish state motor vehicle emission standards. However, Congress passed with bipartisan support, and President Trump signed, three resolutions under the Congressional Review Act (CRA) disapproving three waivers of preemption that the Biden-Harris Administration previously granted.” “Due to CARB’s failure to make a good faith effort to provide the requested information and documents, the Committee requests transcribed interviews with the following individuals if CARB fails to provide the requested information and documents by December 5, 2025: Lauren Sanchez, CARB Chair (from September 2025 to present); Liane Randolph, Former CARB Chair (from December 2021 to September 2025); Steven Cliff, CARB Executive Officer; Shannon Dilley, CARB Chief Counsel; Christopher Grundler, CARB Deputy Executive Officer – Mobile Sources & Incentives; and Robin Lang, Division Chief, CARB Emissions Certification & Compliance Division. “The Committee requests that these transcribed interviews be completed no later than December 12, 2025.” Background: Since President Trump signed the three Congressional Review Act resolutions into law, revoking California’s ability to set state emission standards that mandate the sale of EVs, the state cannot move forward with plans to ban the sale of gas-powered vehicles. The Committee’s August 11, 2025, request sought answers about California’s apparent enforcement of the preempted standards and requested copies of related documents, such as internal guidance CARB provided to its staff, communications with other states, internal correspondence between CARB officials and the Governor’s Office and the Office of Attorney General, and other internal documents concerning CARB’s response to the disapproval of the waivers of federal preemption. The requested information and documents will help the Committee understand how California is implementing the Clean Air Act in light of the federal preemption of state emission standards, and whether the waiver authority in Clean Air Act section 209(b) should be eliminated or otherwise modified. CLICK HERE to read the full letter .

WASHINGTON, D.C.  – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman John Joyce, M.D. (PA-13), Chairman of the Subcommittee on Oversight and Investigations, sent a letter to the Centers for Medicare and Medicaid Services (CMS) requesting a briefing to better understand the Department of Health and Human Services’ (HHS) recent actions and ongoing work to enhance safety within the organ procurement and transplantation system. On Thursday, September 18, 2025, the Department of Health and Human Services (HHS) announced major efforts to improve safety, transparency, and efficiency within the organ procurement and transplantation system, including the decertification of an organ procurement organization (OPO) for the first time in U.S. history. According to the announcement , the decision was made “after an investigation uncovered years of unsafe practices, poor training, chronic underperformance, understaffing, and paperwork errors.” The Committee has a history of ensuring patient safety remains the highest priority in our organ procurement and transplantation system, as evident from the Committee’s work last Congress on organ transplantation and donation issues as well as its oversight this Congress. As a part of its ongoing investigation, the Committee requests that CMS respond to questions, including those related to the decertification of the OPO in South Florida and the prevalence of incidents similar to those outlined in the Health Resources and Services Administration’s (HRSA) investigative report, to ensure patient safety remains a top priority. Read the full letter HERE . “While the Committee applauds efforts taken by CMS to uphold the highest standards of care to which all OPOs are expected to adhere, HHS’s announcement decertifying the Life Alliance Organ Recovery Agency illustrates the urgency of this moment and why the subcommittee is not finished with our oversight of the organ transplant system,” said Chairmen Guthrie and Joyce. “It is our moral obligation as members of Congress to establish safeguards and prevent these harmful practices from persisting further, and we look forward to obtaining answers from the agency about the prevalence of these incidents, as well as how CMS plans to proceed with prioritizing patient safety first and foremost.” Background: During the 118th Congress, the Committee on Energy and Commerce led the passage of the Securing the U.S. Organ Procurement and Transplantation Network Act to both modernize the Organ Procurement and Transplantation Network (OPTN) and allow HRSA to institute a competitive contracting process to find the best contractors for various OPTN functions. This legislation was signed into law on September 22, 2023.  On March 20, 2024, the Committee launched an investigation into the organ procurement and transplantation system by sending a letter to United Network for Organ Sharing (UNOS) requesting information related to concerns surrounding data security and operability, patient safety and equity, and conflicts of interest.   On March 20, 2024, the Committee also sent a letter to HRSA requesting information related to implementation of the Securing the U.S. Organ Procurement and Transplantation Network Act as well as other concerns related to effective oversight and management.  On September 11, 2024, the Subcommittee on Oversight and Investigations held a hearing that focused on the implementation of reforms at the OPTN, including the need for stronger oversight and accountability as well as ongoing patient safety concerns.  During the hearing, questions were raised related to allegations of mismanagement and patient safety concerns after patients began exhibiting signs of increased neurologic function after being previously deemed suitable as an organ donation candidate. Several of these allegations, particularly those related to patient safety, were later substantiated through the findings contained in HRSA’s March 2025 report.  On March 24, 2025, HRSA’s Division of Transplantation issued a report that summarized the findings of its investigation into KYDA, the OPO now known as Network for Hope, which serves Kentucky and parts of Ohio, West Virginia, and Indiana.   HRSA’s investigation examined an “index case” and an additional 351 unique cases of authorized, not recovered (ANR) patients. This means that the patients were considered for donation after circulatory death recovery, but no organs were transplanted. The report showed that nearly 30 percent of the cases “had concerning features.” The concerning features included problems with patient-family interactions, medical assessments and team interactions, recognition of high neurologic function, and recognition and documentation of drugs in records.  On May 28, 2025, HRSA issued a corrective action plan to the OPTN, which directed the OTPN to take specific actions within a specified period of time, including developing a 12-month OPTN monitoring plan for KYDA to address concerns identified. The corrective action plan also requires the OPTN to propose policies for public comment to improve safeguards for potential donation after circulatory death (DCD) patients in the organ procurement process and increase information shared with patient families regarding DCD organ procurement.  On July 22, 2025, the House Committee on Energy and Commerce’s Subcommittee on Oversight and Investigations held a hearing examining concerning practices within our nation’s organ procurement and transplant system that were identified by HRSA’s investigation.  On September 12, 2025, the Committee sent a bipartisan letter to HRSA requesting a briefing on its ongoing oversight of patient safety in our nation’s organ procurement and transplant system. ###

WASHINGTON, D.C. – Yesterday, Congressman John Joyce, M.D. (PA-13), Chairman of the Subcommittee on Oversight and Investigations, and Congressman Gary Palmer (AL-06), Chairman of the Subcommittee on Environment, sent a letter to Gene Dodaro, the Comptroller General of the Government Accountability Office (GAO), requesting an assessment of available or emerging technologies and materials that could be used to supplement critical minerals in semiconductors. “Critical minerals such as lithium, cobalt, and rare earth elements are essential for technologies used in many sectors of the economy, including energy, transportation, national defense, health care, and consumer electronics,” said Chairmen Joyce and Palmer . “These minerals are vulnerable to supply-chain disruptions for several reasons, including U.S. reliance on foreign sources, as well as the rapid growth in demand for critical minerals in the U.S. and abroad.” CLICK HERE to read the full letter. The letter asks the GAO to examine: The status of domestic technologies and supplemental materials, such as critical minerals found in mine waste, tailings, or reclaimed from end-of-life batteries and electronic waste, that can serve as substitutes for foreign-sourced critical minerals from non-allied nations needed for semiconductors and energy grid or power electronics, including impacts on material and product performance. Key technological challenges to the development or adoption of these domestic supplemental and materials to advance the diversification of U.S. critical mineral sources. BACKGROUND: In May, the Subcommittee on Oversight and Investigations held a hearing on ways to enhance our critical mineral supply chains. Energy and Commerce Committee Republicans are committed to strengthening our critical mineral supply chains and finding solutions to reduce our reliance on foreign sources, particularly when it comes to foreign adversaries like China. The Trump Administration has also worked hard to bolster these supply chains. Critical minerals are essential to American technologies and industries, and finding innovative domestic solutions that can contribute to our independence from non-allied nations is essential as we work to onshore American innovation and strengthen our national security. ###

WASHINGTON, D.C. – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, Congressman John Joyce, M.D. (PA-13), Chairman of the Subcommittee on Oversight and Investigations, and Congressman Gary Palmer (AL-06), Chairman of the Subcommittee on Environment, sent a letter to Environmental Protection Agency (EPA) Administrator Lee Zeldin requesting information on how far-left organizations received billions of dollars in the final days of the previous administration through the Greenhouse Gas Reduction Fund (GGRF).  “In the final days of the Biden-Harris Administration, the EPA put their far-left allies ahead of the American people, giving away Greenhouse Gas Reduction Fund grants worth nearly $30 billion to recipients who were not equipped to receive such large amounts of funding,” said Chairmen Guthrie, Joyce, and Palmer. “By requesting documentation about this grant process from the EPA, Republicans on the Committee on Energy and Commerce are continuing our work to root out waste, fraud, and abuse while being good stewards of taxpayer dollars.”  This letter follows requests sent to eight nonprofits who were awarded more than $20 billion earlier this year through the GGRF. Key excerpt from the letter: “The Committee finds the potential for financial mismanagement particularly worrisome, as some of the grantees’ previous revenues were only a small fraction of the GGRF funds they received, which raises questions about whether the grant recipients can adequately manage grant amounts that are significantly larger than their previously documented revenue.” “The Committee seeks to ensure that the federal government is a good steward of taxpayer dollars and to continue supporting EPA’s efforts in combatting waste, fraud, and abuse within the GGRF program. To assist with the Subcommittee’s investigation of GGRF and support the Administration’s efforts, the Committee requests the following documents no later than November 19, 2025: The complete grant file for the three NCIF grantees and the five CCIA grantees, including the application submitted by the organization with all supporting documentation and appendices, any additional information requested by EPA, and any memos on changes to the grant terms and conditions. The scoring breakdown and rational for each score for all the NCIF and CCIA applicants included in the final rankings lists for the top-ranked applications, including any changes to scoring or rescores and rationale for why those changes occurred. Any checklist or guidance for EPA grants employees on what steps they should be taking to conduct appropriate pre-award due diligence and to ensure all required paperwork and documentation is submitted and verified. This should include briefing materials used to advise the Administrator, Deputy Administrator, Chief of Staff, General Counsel, Associate Administrator for Mission Support, and Associate Administrator for the Office of Air and Radiation about the selection of NCIF grantees and CCIA grantees. Any reports received from Citibank or the U.S. Treasury regarding the account balances or transactions histories of the GGRF accounts for the three NCIF grantees and the five CCIA grantees and any of their sub-awardees. Any progress reports received from the three NCIF grantees and the five CCIA grantees. The names of all panel chairs, senior review panels, selection officials, and all individuals involved in the review panels for all the NCIF and CCIA applicants included in the final rankings lists for the top-ranked applications.” Background: The Inflation Reduction Act (IRA) authorized the Environmental Protection Agency (EPA) to create and implement a $27 billion GGRF program. Of this appropriation, $20 billion was awarded to just eight grant recipients; with $14 billion awarded to three grant recipients under the National Clean Investment Fund (NCIF) program and $6 billion awarded to five grant recipients under the Clean Communities Investment Accelerator (CCIA) program.  CLICK HERE to read the full letter. Read More About this Ongoing Investigation: “SCOOP: Biden-era grant program described as ‘gold bar’ scheme by Trump EPA administrator under scrutiny” –   Fox News “EXCLUSIVE: Key Committee Demands Docs in Biden ‘Gold Bars’ Probe” – Daily Caller ###